N-[6-(3-fluoropyridine-4-carbonyl)-7,8-dihydro-5H-1,6-naphthyridin-3-yl]-1,5-dimethylpyrazole-3-carboxamide
C20H19FN6O2 — CID 155918192
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[6-(3-fluoropyridine-4-carbonyl)-7,8-dihydro-5H-1,6-naphthyridin-3-yl]-1,5-dimethylpyrazole-3-carboxamide
N-[6-(3-fluoropyridine-4-carbonyl)-7,8-dihydro-5H-1,6-naphthyridin-3-yl]-1,5-dimethylpyrazole-3-carboxamide (PubChem CID 155918192) has the molecular formula C20H19FN6O2 and a molecular weight of 394.41 g/mol. Its IUPAC name is N-[6-(3-fluoropyridine-4-carbonyl)-7,8-dihydro-5H-1,6-naphthyridin-3-yl]-1,5-dimethylpyrazole-3-carboxamide.
Molecular Properties
| Compound Name | N-[6-(3-fluoropyridine-4-carbonyl)-7,8-dihydro-5H-1,6-naphthyridin-3-yl]-1,5-dimethylpyrazole-3-carboxamide |
|---|---|
| PubChem CID | 155918192 |
| Molecular Formula | C20H19FN6O2 |
| Molecular Weight | 394.41 g/mol |
| Exact Mass | 394.16 |
| IUPAC Name | N-[6-(3-fluoropyridine-4-carbonyl)-7,8-dihydro-5H-1,6-naphthyridin-3-yl]-1,5-dimethylpyrazole-3-carboxamide |
| SMILES | Cc1cc(C(=O)Nc2cnc3c(c2)CN(C(=O)c2ccncc2F)CC3)nn1C |
| InChI | InChI=1S/C20H19FN6O2/c1-12-7-18(25-26(12)2)19(28)24-14-8-13-11-27(6-4-17(13)23-9-14)20(29)15-3-5-22-10-16(15)21/h3,5,7-10H,4,6,11H2,1-2H3,(H,24,28) |
| InChIKey | NGCBXVKZLAVVHH-UHFFFAOYSA-N |
| XLogP | 2.11 |
| TPSA | 93.01 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 394.41 |
| LogP ≤ 5 | 2.11 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155918192 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.